Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-24-050113

Director bought 647 shares at an average $1.17 ($755)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2024-11-01 Purchase 10b5-1 +38 $1.15 $44 29,055 D
Young Caroline Director 2024-11-04 Purchase 10b5-1 +25 $1.17 $29 29,080 D
Young Caroline Director 2024-11-05 Purchase 10b5-1 +38 $1.20 $46 29,118 D
Young Caroline Director 2024-11-06 Purchase 10b5-1 +38 $1.20 $46 29,156 D
Young Caroline Director 2024-11-07 Purchase 10b5-1 +38 $1.17 $44 29,194 D
Young Caroline Director 2024-11-08 Purchase 10b5-1 +38 $1.18 $45 29,232 D
Young Caroline Director 2024-11-11 Purchase 10b5-1 +38 $1.20 $46 29,270 D
Young Caroline Director 2024-11-12 Purchase 10b5-1 +38 $1.20 $46 29,308 D
Young Caroline Director 2024-11-13 Purchase 10b5-1 +38 $1.20 $46 29,346 D
Young Caroline Director 2024-11-14 Purchase 10b5-1 +38 $1.19 $45 29,384 D
Young Caroline Director 2024-11-15 Purchase 10b5-1 +38 $1.17 $44 29,422 D
Young Caroline Director 2024-11-18 Purchase 10b5-1 +38 $1.18 $45 29,460 D
Young Caroline Director 2024-11-19 Purchase 10b5-1 +38 $1.15 $44 29,498 D
Young Caroline Director 2024-11-20 Purchase 10b5-1 +43 $1.13 $49 29,541 D
Young Caroline Director 2024-11-21 Purchase 10b5-1 +43 $1.09 $47 29,584 D
Young Caroline Director 2024-11-22 Purchase 10b5-1 +16 $1.07 $17 29,600 D
Young Caroline Director 2024-11-25 Purchase 10b5-1 +16 $1.09 $17 29,616 D
Young Caroline Director 2024-11-26 Purchase 10b5-1 +16 $1.09 $17 29,632 D
Young Caroline Director 2024-11-27 Purchase 10b5-1 +16 $1.15 $18 29,648 D
Young Caroline Director 2024-11-29 Purchase 10b5-1 +16 $1.32 $21 29,664 D
Open-market purchases · 647 sh · avg $1.17 · $755
Loading xslF345X05/wk-form4_1733436307.xml…